Transposition of the great vessels prevention

Revision as of 16:05, 10 August 2011 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Transposition of the great vessels Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Dextro-transposition of the great arteries
L-transposition of the great arteries

Pathophysiology

Causes

Differentiating Transposition of the great vessels from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Palliative care
Corrective surgery
Post-operative care
Follow up

Prevention

Reproduction

Case Studies

Case #1

Transposition of the great vessels prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transposition of the great vessels prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transposition of the great vessels prevention

CDC on Transposition of the great vessels prevention

Transposition of the great vessels prevention in the news

Blogs on Transposition of the great vessels prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Transposition of the great vessels prevention

Overview

Prevention

General

The development of a fetal heart starts during the first trimester of pregnancy. Thus, many a times the fetal heart has already gone through the development when the female became aware of being pregnant. Some steps taken before and during pregnancy that can help in preventing the congenital heart disease are as follow-

  • Ensuring that the female is immunized to Rubella before getting pregnant.
  • Folate supplementation (400micrograms/day. All females planning for pregnancy should start taking folate on daily basis as the birth defects occur most commonly during first trimester of pregnancy even befor th efemale is aware that she is pregnant.
  • Avoid intravenous drug abuse (street drugs)
  • Avoid viral infections. Ensure proper and complete treatment of upper respiratory tract infections.
  • Avoid alcohol
  • Prescription medications, such as lithium, anti-acne drugs (retinoic acid) and anti-epileptic therapy
  • X-rays
  • Strong chemicals (solvents)

Specific

  • Women with some diseases like diabetes, seizures etc should consult their physicians before and during pregnancy for special management strategies for these diseases to prevent the occurrence of congenital heart diseases. Females with phenylketonuria may need to follow a special phenylketoneuric diet before pregnancy and during the first trimester.
  • Genetic counselling can be offered to parents who have previous history of a child with birth defect or with family history.